Composite collagen eye drops
A technology of collagen and original protein, which is applied in the field of medical medicine, can solve the problems of short effective time of medicine, poor penetration of medicine, lack of biological activity, etc., and achieve the effect of prolonging the effective time, reducing visual fatigue and keeping eyeballs moist
CN1927392AActive Publication Date: 2007-03-14GUANGZHOU TRAUER BIOTECH
0 Cites 14 Cited by
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2007-03-14
Abstract
The invention relates to a kind of compound collagen protein gutta, which is the mixture of collagen protein and antibiotics. For every 100ml compound collagen gutta, there is 10-500mg collagen protein which is extracted from the tendon, 100-600mg antibiotics which include one or two kinds of the following antibiotics: ofloxacin, alficetin, tenebrimycin, while the rest is the iso-osmia, which is 5% amylaceum solution. The product has three main functions: resist bacteria and inflammation; help to keep the eyeball moist, promote the agglutination and relieve the asthenopia; be used in the treatment of the damage to the cornea, keratohelcosis, keratitis punctata, slight chemical injury to cornea as well as the thermal damage to the cornea; prevent the ophthalmia and relieve the asthenopia; prevent the cohesive property of the collagen from being diluted so as to extend the effective time of the gutta; resist the bacteria as well as promote the agglutination.
Need to check novelty before this filing date? Find Prior Art